KF-0210

· Keythera Pharmaceuticals (Australia) Pty Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KF-0210, covering 2024-09-24 to 2024-09-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of KF-0210 in Advanced Solid Tumors Patients [Phase 1]